Anti-HMGB1 neutralizing antibody ameliorates neutrophilic airway inflammation by suppressing dendritic cell-mediated th17 polarization

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Zhang, Fang ^a   Huang, Gang ^b   Hu, Bo ^c   Fang, Li Ping ^a   Cao, E Hong ^a   Xin, Xiao Feng ^a   Song, Yong ^a   Shi, Yi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c The 105th Hospital of PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 17; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; OVALBUMIN; UNCLASSIFIED DRUG; CYTOKINE; GLYCOPROTEIN P 15095; HMGB1 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS CELL; LYMPHOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; PNEUMONIA; POLARIZATION; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; TH17 CELL; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; COCULTURE; CYTOLOGY; FLOW CYTOMETRY; IMMUNOLOGY; INFLAMMATION; LUNG; LUNG LAVAGE; METABOLISM;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD11C; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HMGB1 PROTEIN; INFLAMMATION; INTERLEUKIN-23; LIPOPOLYSACCHARIDES; LUNG; LYMPHOCYTES; MICE; MICE, INBRED BALB C; NEUTROPHILS; OVALBUMIN; PHENOTYPE; TH17 CELLS;

EID: 84901779949     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/257930     Document Type: Article

References (34)

1. Deckers J., Branco M. F., Hammad H., Innate immune cells in asthma. Trends in Immunology 2013 34 11 540 547 10.1016/j.it.2013.08.004
2. Newcomb D. C., Peebles R. S. Jr., Th17-mediated inflammation in asthma. Current Opinion in Immunology 2013 25 6 755 760 10.1016/j.coi.2013.08.002
3. Durrant D. M., Metzger D. W., Emerging roles of T helper subsets in the pathogenesis of asthma. Immunological Investigations 2010 39 4-5 526 549 2-s2.0-77952128925 10.3109/08820131003615498
4. Mishra A., Yao X., Levine S. J., From bedside to bench to clinic trials: identifying new treatments for severe asthma. Disease Models & Mechanisms 2013 6 4 877 888 10.1242/dmm.012070
5. Jaffar Z., Ferrini M. E., Girtsman T. A., Roberts K., Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. European Journal of Immunology 2009 39 12 3307 3314 2-s2.0-73249122393 10.1002/eji.200939498
6. Traves S. L., Donnelly L. E., Th17 cells in airway diseases. Current Molecular Medicine 2008 8 5 416 426 2-s2.0-53849122647 10.2174/ 156652408785160998
7. Marland G., Bakker A. B., Adema G. J., Figdor C. G., Dendritic cells in immune response induction. Stem Cells 1996 14 5 501 507 10.1002/stem.140501 (Pubitemid 26322111)
8. Pearce E. J., Kane C. M., Sun J., Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcome of the adaptive immune response. Chemical Immunology and Allergy 2006 90 82 90 2-s2.0-33144477741 (Pubitemid 43265669)
9. Lagranderie M., Abolhassani M., Vanoirbeek J. A., Mycobacterium bovis bacillus Calmette-Guérin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. Journal of Immunology 2010 184 2 1062 1070 2-s2.0-76249119555 10.4049/jimmunol.0901822
10. Lewkowich I. P., Lajoie S., Clark J. R., Herman N. S., Sproles A. A., Wills-Karp M., Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice. PLoS ONE 2008 3 12 2-s2.0-57549113463 10.1371/journal.pone.0003879 e3879
11. Klune J. R., Dhupar R., Cardinal J., Billiar T. R., Tsung A., HMGB1: endogenous danger signaling. Molecular Medicine 2008 14 7-8 476 484 2-s2.0-48149096398 10.2119/2008-00034.Klune
12. Duan L., Wang C. Y., Chen J., High-mobility group box 1 promotes early acute allograft rejection by enhancing IL-6-dependent Th17 alloreactive response. Laboratory Investigation 2011 91 1 43 53 2-s2.0-78650774420 10.1038/labinvest.2010.141
13. Su Z., Sun C., Zhou C., HMGB1 blockade attenuates experimental autoimmune myocarditis and suppresses Th17-cell expansion. European Journal of Immunology 2011 41 12 3586 3595 2-s2.0-82255164204 10.1002/eji.201141879
14. He Z., Shotorbani S. S., Jiao Z., HMGB1 promotes the differentiation of Th17 via up-regulating TLR2 and IL-23 of CD14+ monocytes from patients with rheumatoid arthritis. Scandinavian Journal of Immunology 2012 76 5 483 490 10.1111/j.1365-3083.2012.02759.x
15. Zhang F., Shi Y., Song Y., The association of HMGB1 expression and neutrophil account or IL-17 level in the lung of asthmatic mouse. Geriatrics & Health Care 2012 18 3 144 146
16. Kim Y. K., Oh S. Y., Jeon S. G., Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. Journal of Immunology 2007 178 8 5375 5382 2-s2.0-34247135082 (Pubitemid 46595324)
17. Zhang F., Huang G., Hu B., Song Y., Shi Y., A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clinical and Experimental Immunology 2011 164 2 256 264 2-s2.0-79953781744 10.1111/j.1365-2249.2011.04328.x
18. Kim Y. S., Hong S. W., Choi J. P., Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type 17 T helper cells in the airways. Journal of Immunology 2009 183 8 5113 5120 2-s2.0-77949385479 10.4049/jimmunol.0901566
19. Zhang F., Huang G., Hu B., Song Y., Shi Y., Induction of immune tolerance in asthmatic mice by vaccination with DNA encoding an allergen-cytotoxic T lymphocyte-associated antigen 4 combination. Clinical and Vaccine Immunology 2011 18 5 807 814 2-s2.0-79955719651 10.1128/CVI.00434-10
20. Ebina M., Taniguchi H., Miyasho T., Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis. Pulmonary Medicine 2011 2011 9 916486 10.1155/2011/916486
21. Bai H., Cheng J., Gao X., IL-17/Th17 promotes type 1 T cell immunity against pulmonary intracellular bacterial infection through modulating dendritic cell function. Journal of Immunology 2009 183 9 5886 5895 2-s2.0-77951227349 10.4049/jimmunol.0901584
22. Masten B. J., Olson G. K., Kusewitt D. F., Lipscomb M. F., Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice. Journal of Immunology 2004 172 7 4077 4083 2-s2.0-1642265007 (Pubitemid 38375219)
23. Lin X., Yang H., Sakuragi T., Alpha-chemokine receptor blockade reduces high mobility group box 1 protein-induced lung inflammation and injury and improves survival in sepsis. The American Journal of Physiology: Lung Cellular and Molecular Physiology 2005 289 4 L583 L590 2-s2.0-25444508718 10.1152/ajplung.00091.2005 (Pubitemid 41361668)
24. Lyakh L., Trinchieri G., Provezza L., Carra G., Gerosa F., Regulation of interleukin-12/interleukin-23 production and the T-helper 17 response in humans. Immunological Reviews 2008 226 1 112 131 2-s2.0-55149092303 10.1111/j.1600-065X.2008.00700.x
25. Yang H., Tracey K. J., Targeting HMGB1 in inflammation. Biochimica et Biophysica Acta 2010 1799 1-2 149 156 2-s2.0-74449089862 10.1016/j.bbagrm.2009. 11.019
26. Orlova V. V., Choi E. Y., Xie C., A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. The EMBO Journal 2007 26 4 1129 1139 2-s2.0-33847193122 10.1038/sj.emboj.7601552
27. Bassi R., Giussani P., Anelli V., HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. Journal of Neuro-Oncology 2008 87 1 23 33 2-s2.0-38649103181 10.1007/s11060-007-9488-y
28. Rovere-Querini P., Capobianco A., Scaffidi P., HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Reports 2004 5 8 825 830 2-s2.0-4444261780 10.1038/sj.embor.7400205 (Pubitemid 39199174)
29. Dumitriu I. E., Baruah P., Valentinis B., Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. Journal of Immunology 2005 174 12 7506 7515 2-s2.0-20444426542 (Pubitemid 40806253)
30. Manfredi A. A., Capobianco A., Esposito A., Maturing dendritic cells depend on RAGE for in vivo homing to lymph nodes. Journal of Immunology 2008 180 4 2270 2275 2-s2.0-42149172380
31. Wakashin H., Hirose K., Iwamoto I., Nakajima H., Role of IL-23-Th17 cell axis in allergic airway inflammation. International Archives of Allergy and Immunology 2009 149 supplement 1 108 112 2-s2.0-67650243020 10.1159/000211382
32. Yang D., Chen Q., Yang H., Tracey K. J., Bustin M., Oppenheim J. J., High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. Journal of Leukocyte Biology 2007 81 1 59 66 2-s2.0-33845885124 10.1189/jlb.0306180 (Pubitemid 46021253)
33. Allam J. P., Duan Y., Heinemann F., IL-23-producing CD68+ macrophage-like cells predominate within an IL-17-polarized infiltrate in chronic periodontitis lesions. Journal of Clinical Periodontology 2011 38 10 879 886 2-s2.0-80052722890 10.1111/j.1600-051X.2011.01752.x
34. Musumeci D., Roviello G. N., Montesarchio D., An overview on HMGB1 inhibitors as potential therapeutic agents in HMGB1-related pathologies. Pharmacology & Therapeutics 2014 141 3 347 357 10.1016/j.pharmthera.2013.11. 001